Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sparaventi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Haematologica|May 1, 1986
In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantationA Manna, G Sparaventi, M Palazzi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Cryopreservation of bone marrow]A Porcellini, A Manna, G Sparaventi, et al.
Il Giornale Di Chirurgia|August 1, 1991
[An apparently primary lymphoma of the testicle]F Belbusti, P Signoretti, M R Tondi, et al.
Bone Marrow Transplantation|January 1, 1989
Purging by dye-mediated photosensitizationA Porcellini, M Manna, M T Marchetti-Rossi, et al.
International Journal of Cell Cloning|July 1, 1989
Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitizationA Porcellini, M T Rossi, A Manna, et al.
Minerva Chirurgica|February 29, 1988
[Primary gastric lymphoma. Diagnostic and therapeutic observations on 12 cases]D De Poda, L Beluffi, A Fattori, et al.
Tumori|December 31, 1987
Malignant melanoma of the glans penis in a chronic myeloid leukemia patient after busulfan therapyG Sparaventi, A Manna, P Muretto, et al.
Haematologica|November 1, 1992
Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral bloodL Moretti, L Giuliodori, S Stramigioli, et al.
Experimental Hematology|December 1, 1984
Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cellsA Porcellini, A Manna, N Talevi, et al.
Blood|November 1, 1987
Limiting-dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540A Porcellini, N Talevi, M T Marchetti-Rossi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Haematologica|May 1, 1986
In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantationA Manna, G Sparaventi, M Palazzi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Cryopreservation of bone marrow]A Porcellini, A Manna, G Sparaventi, et al.
Il Giornale Di Chirurgia|August 1, 1991
[An apparently primary lymphoma of the testicle]F Belbusti, P Signoretti, M R Tondi, et al.
Bone Marrow Transplantation|January 1, 1989
Purging by dye-mediated photosensitizationA Porcellini, M Manna, M T Marchetti-Rossi, et al.
International Journal of Cell Cloning|July 1, 1989
Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitizationA Porcellini, M T Rossi, A Manna, et al.
Minerva Chirurgica|February 29, 1988
[Primary gastric lymphoma. Diagnostic and therapeutic observations on 12 cases]D De Poda, L Beluffi, A Fattori, et al.
Tumori|December 31, 1987
Malignant melanoma of the glans penis in a chronic myeloid leukemia patient after busulfan therapyG Sparaventi, A Manna, P Muretto, et al.
Haematologica|November 1, 1992
Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral bloodL Moretti, L Giuliodori, S Stramigioli, et al.
Experimental Hematology|December 1, 1984
Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cellsA Porcellini, A Manna, N Talevi, et al.
Blood|November 1, 1987
Limiting-dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540A Porcellini, N Talevi, M T Marchetti-Rossi, et al.
Pageof 2